Six months after lockdown was first announced in the UK, the country is seeing a rise in Covid-19 infections. Jeremy Farrar reflects on the measures we need to suppress transmission.
Wellcome launched COVID-Zero in April to mobilise urgent donations from businesses and philanthropists for Covid-19 research. As we draw the campaign to a close, Mark Henderson discusses what it has achieved.
Covid-19 is exacerbating existing health, economic and social inequalities in the US and across the world. Claude Lopez explains why investing in coronavirus treatment research and development is an imperative for business leaders and philanthropists.
The Covid-19 pandemic is a social and an economic crisis just as much as it is a health crisis – its repercussions, severe and far-reaching, are being felt across the world.
We need to understand the impact of Covid-19 on wider health issues to shape better public health responses and limit long-term consequences. Drug resistance is one of these, Gemma Buckland-Merrett explains.
The world is waiting eagerly for Covid-19 vaccines to be developed as quickly as possible. But to make sure they are safe and effective, the clinical trials that test them have to be robust. So how do trials achieve this?
As we'll soon start to see the results of the first vaccines coming through late-stage clinical trials, Jeremy Farrar explains why we should be cautiously optimistic.
Covid-19 is already causing wider consequences for societies, national economies and global relations, and these will continue for years to come. Three experts share insights on how we can better respond to the pandemic.
The Wellcome Photography Prize 2020 overall winner is Arseniy Neskhodimov for his series ‘Prozac’, a unique portrayal of living with depression.
It’s time to see health misinformation differently. We’re calling for the health and research sector to step up and play its role in creating a healthier internet.